Brightside Health raised $33M in a strategic Series C led by S32 to fuel its growth into new markets and new offerings.
Brightside Health raised $33M in a strategic Series C led by S32 to fuel its growth into new markets and new offerings.
03/26/24, 5:08 PM
Location
san franciscoMoney raised
$33 million
Industry
health care
Round Type
series c
Investors
Triventures, Mousse Partners, Acme, Anne Wojcicki, Time Bio Ventures, Kennedy Lewis, S32
Brightside Health announced a $33-million strategic Series C raise led by S32, with participation from Kennedy Lewis, Time BioVentures, Anne Wojcicki, ACME, Mousse Partners, and Triventures. The raise will be used to fuel Brightside Health’s growth into new markets and new offerings, especially to expand with Medicare, Medicaid, and other underserved populations, and to deliver measurably better outcomes.
Company Info
Location
2471 peralta street
san francisco, california, united states
Additional Info
Brightside Health delivers life-saving mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk. Powered by proprietary AI, purpose-built technology, and a world-class clinician network, Brightside Health combines precision psychiatry and leading-edge therapeutic techniques to improve patient outcomes across the entire clinical spectrum, affordably and at scale. Brightside Health can be paid for with insurance in all 50 states and D.C., with appointments available in 48 hours or less.